Insider Transactions in Q2 2025 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Susan Moran |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+31.0%
|
-
|
|
Jun 18
2025
|
Scott Andrew Smith |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+6.81%
|
-
|
|
Jun 18
2025
|
Sylvia Mcbrinn |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+28.44%
|
-
|
|
Jun 18
2025
|
Mary Ann Gray |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+23.29%
|
-
|
|
Jun 18
2025
|
Lawrence Steinman |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+23.05%
|
-
|
|
Jun 18
2025
|
Eddie Williams |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+28.08%
|
-
|
|
May 31
2025
|
Christian Vasquez |
SELL
Payment of exercise price or tax liability
|
Direct |
1,566
-0.55%
|
$0
$0.41 P/Share
|
|
May 31
2025
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,371
-0.69%
|
$0
$0.41 P/Share
|
|
May 31
2025
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,729
-0.74%
|
$0
$0.41 P/Share
|
|
May 31
2025
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,347
-0.28%
|
$0
$0.41 P/Share
|